U.S. Paper and Forestry Products Stock News

Earlier this month, Absolute Climate announced a partnership with Northern Trust to deliver a regulated, infrastructure-rich carbon credit issuance system, integrating third-party certification and digital lifecycle management for project developers and buyers through the Northern Trust Carbon Ecosystem™. This collaboration aims to address credibility and transparency in carbon markets by aligning rigorous, independent certification with regulated credit issuance, offering enhanced support...

Perella Weinberg Partners recently announced the appointment of David Wyles as Partner, based in London, to lead its UK and European businesses and provide strategic and financial advisory services across sectors. Wyles brings nearly three decades of high-level M&A and restructuring experience from Greenhill & Co., reflecting a move to strengthen the firm’s European expertise and leadership. We’ll explore how the addition of such a seasoned industry executive could influence Perella Weinberg...

Earlier this year, multiple law firms filed class action lawsuits against Flywire Corporation following its disclosure of disappointing financial results, lowered revenue guidance, and restructuring plans that included a workforce reduction of about 10%. A unique aspect of these lawsuits is the accusation that Flywire understated the negative business impacts of international permit and visa restrictions, especially in key education markets such as Canada and Australia. We'll now examine how...

Deciding what to do with Bristol-Myers Squibb stock right now might feel like a coin toss, but there is more than luck at play. The stock closed recently at $47.15, and if you have been watching the rollercoaster of news out of Washington and Brussels, you know the ride has been eventful. Over the past year, the share price has moved up just 1.6%, with more dramatic swings when you zoom out and in: it is down 17.0% year-to-date and has dropped 24.0% over the last three years. So what is...

ARS Pharmaceuticals (SPRY) is catching investor attention this week after sharing real-world clinical data that puts its flagship product, neffy, squarely in the spotlight. Unlike traditional epinephrine injections, neffy is a needle-free nasal spray aimed at treating anaphylaxis. The company announced that neffy demonstrated an 89.2% success rate in 545 patients, very close to what is seen with the tried-and-true injection method. The findings, now accepted for publication in a leading...

What’s Behind Viking Therapeutics' Recent Moves? If you hold shares of Viking Therapeutics (VKTX) or are thinking about jumping in, the stock’s roller-coaster ride this year is hard to ignore. With no single event triggering the latest price action, the subtle shifts in VKTX’s value are drawing attention. Investors are left wondering if the market is signaling something new about the company’s prospects or just recalibrating after a stretch of volatility. Even without a headline-grabbing...

On September 9, 2025, Cboe Global Markets announced plans to launch Cboe Continuous futures for bitcoin and ether on its U.S. futures exchange, pending regulatory review. This move introduces single, long-dated, cash-settled contracts with daily spot price alignment, aiming to simplify digital asset exposure and risk management for U.S. traders. We'll explore how the introduction of Cboe Continuous futures in digital assets could influence the long-term investment outlook for the company. AI...

Freddie Mac recently announced the pricing of its second Seasoned Credit Risk Transfer Trust (SCRT) offering of 2025, involving the securitization of about US$707 million in seasoned re-performing loans with both guaranteed senior and non-guaranteed subordinate securities. This securitization marks a significant move in Freddie Mac’s approach to managing less-liquid assets and mitigating credit and market risk in its investment portfolio. To assess the impact on Freddie Mac’s investment...

In recent days, analysts have shown strong agreement that Sezzle will report earnings surpassing previous estimates and have upgraded its ranking to reflect this optimism. This surge in analyst confidence highlights a growing belief in Sezzle's near-term financial outlook among investment professionals. We'll now explore what rising analyst optimism and stronger earnings expectations might mean for Sezzle's broader investment narrative. Trump's oil boom is here - pipelines are primed to...

Trying to figure out if now’s the right moment to buy, sell, or just sit tight with Amazon.com stock? You’re hardly alone. Amazon continues to draw the attention of investors, and with good reason. Over the past year, shares have popped by 24.8%. Looking farther back, a 79.2% gain in the last three years showcases the kind of long-term performance that keeps Amazon in the spotlight. More recent moves, including a 1.9% lift just in the last week, make it tough to ignore for those watching...

If you've been following Global-E Online (NasdaqGS:GLBE), you likely caught the news that the company’s Board just signed off on a share repurchase program worth up to $200 million. This program will be funded from cash on hand as well as future cash generated by the business. For investors, buybacks like this are always intriguing, as they often indicate that leadership feels the stock is undervalued or that they are confident about future prospects. It is not common for a growth-focused...

Playhouse MD™ announced a distribution alliance with McKesson Medical-Surgical, bringing its doctor-designed, kid-friendly medical devices to Amazon and expanding access to pediatric care solutions for families across the US. This marks the first time McKesson Medical-Surgical has included a play-based pediatric brand in its large portfolio, reflecting ongoing moves toward consumer-focused healthcare offerings. We'll explore how McKesson's entry into consumer pediatric devices via Amazon...

Webflow recently announced a new integration with Adobe Marketo Engage and showcased its expanded collaboration with Adobe Express at Adobe Summit 2025, bringing advanced AI-driven image creation and marketing personalization tools directly into the Webflow platform for marketing teams. This integration is designed to help marketers leverage audience data and generative AI-powered content creation to enhance website personalization and improve campaign optimization within a unified...

DocuSign recently reported its second quarter earnings, showing year-over-year revenue growth to US$800.64 million but a substantial drop in net income to US$62.97 million, along with updates to its board of directors and a completed share buyback tranche. The company’s new board appointments, including a CEO and seasoned finance executive as board chair, may signal shifts in governance and future strategic direction. We'll examine how DocuSign's weaker net income alongside governance...

ZEEKR Intelligent Technology Holding Limited announced that in August 2025, it delivered 44,843 vehicles across its Zeekr and Lynk & Co brands, marking increases of 10.6% year-over-year and 1.5% compared to the previous month. This solid performance, paired with the unveiling of new hybrid technologies and the upcoming Zeekr 9X model, underscores the company's ongoing push to enhance innovation and broaden its customer reach in the electric vehicle sector. We'll now examine how August's...

If you have been watching TransUnion (TRU) lately, the company’s shares just made a decisive move higher. The catalyst? TransUnion announced a strategic partnership with Truework to ramp up distribution and coverage for income and employment verification solutions, leveraging an earlier minority stake in Truework. This collaboration is being promoted as a way to provide broader, more efficient verification coverage for lenders and streamline the process for consumers, potentially boosting...

If you have been watching Veritone (VERI) lately, the latest surge in attention is easy to understand. D. Boral Capital just delivered a substantial analyst upgrade, spotlighting the company’s Data Refinery business and its ongoing pivot toward government and law enforcement contracts. The buzz grew after Veritone highlighted new projects and a much larger pipeline at a recent investment conference, sparking some big questions about what’s ahead for shareholders. This comes after a year...

TAT Technologies (NasdaqGM:TATT) is catching investors’ attention this week, and it is easy to see why. The company has announced the launch of FutureWorks, a new Center for Aerospace Innovation based in Charlotte, North Carolina. This event goes beyond a traditional ribbon-cutting, as TAT has also revealed its first customer partnership for its advanced thermal management systems. The message is clear: TAT’s push into next-generation aerospace solutions is now validated in the real world and...

REV Group, Inc. recently reported third quarter results showing year-over-year growth in sales to US$644.9 million and net income to US$29.1 million, while also raising its full-year earnings guidance and affirming a regular quarterly cash dividend of US$0.06 per share, payable in October 2025. The company signaled ongoing interest in disciplined acquisitions to complement internal investments and announced completion of its previously authorized share buyback program, further reflecting its...

Clover Health Investments (CLOV) is making headlines again, this time with the introduction of a new AI-powered scribing tool on its Counterpart Assistant platform. This move is more than just another tech update; it could have real implications for how efficiently smaller practices operate and how Clover Health is positioned in the competitive healthcare technology space. Recent analyst commentary has also highlighted improved ratings for the company’s Medicare Advantage plans, progress in...

Microbot Medical has grabbed the spotlight with news that could shift the company’s direction in a major way. After securing FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, the first single-use, remotely operated device approved for peripheral endovascular procedures, the company is now cleared to commercialize this breakthrough technology in the U.S. market. By removing the typical hurdles of expensive capital equipment and specialized infrastructure, LIBERTY could give...

LGI Homes (LGIH) has been quietly catching some attention recently, especially among investors wondering if the current stock movement signals something bigger ahead. There has not been a single defining event to push shares in either direction. Whenever a stock makes noticeable moves without an obvious trigger, it tends to spark curiosity about what the market might be anticipating. In the case of LGI Homes, this is a moment where investors are pausing to ask if there is an underlying story...

Northrop Grumman (NOC) has caught investor attention again this week, even in the absence of headline-making news or a specific market-moving event. Sometimes, these quieter stretches can be just as interesting, prompting thoughtful investors to look closer. Did something change beneath the surface, or is the market simply reassessing the company’s longer-term prospects? For shareholders, these periods often signal an opportunity to reassess valuation and refocus on fundamentals. Looking at a...

In recent days, Hesai Group announced plans to raise up to HK$4.46 billion through a follow-on equity offering and new Hong Kong listing, while also showcasing advanced lidar technology and celebrating an expanded partnership with autonomous vehicle leader Motional. Hesai’s decision to pursue capital raising and a Hong Kong listing in the context of ongoing U.S.-China tensions highlights its commitment to global expansion and diversification of its investor base. We’ll examine how Hesai’s...